Yonhap Infomax NewsCelltrion has completed all regulatory reviews for its acquisition of Eli Lilly’s US manufacturing facility, paving the way for expanded biopharmaceutical production and CMO business growth.
#YonhapInfomax #Celltrion #EliLilly #AntitrustReview #ManufacturingFacility #700BillionWonInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90145
#YonhapInfomax #Celltrion #EliLilly #AntitrustReview #ManufacturingFacility #700BillionWonInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90145
Celltrion Completes Final Antitrust Review for Acquisition of Eli Lilly’s US Manufacturing Facility
Celltrion has completed all regulatory reviews for its acquisition of Eli Lilly’s US manufacturing facility, paving the way for expanded biopharmaceutical production and CMO business growth.